- Report
- March 2025
- 50 Pages
Malaysia
From €533EUR$600USD£465GBP
- Report
- March 2025
- 50 Pages
Bangladesh
From €533EUR$600USD£465GBP
- Report
- March 2025
- 50 Pages
Vietnam
From €533EUR$600USD£465GBP
- Report
- March 2025
- 50 Pages
Philippines
From €533EUR$600USD£465GBP
- Report
- March 2025
- 50 Pages
Thailand
From €533EUR$600USD£465GBP
- Report
- March 2025
- 50 Pages
Singapore
From €533EUR$600USD£465GBP
- Report
- March 2025
- 50 Pages
Taiwan
From €533EUR$600USD£465GBP
- Report
- March 2025
- 50 Pages
Indonesia
From €533EUR$600USD£465GBP
- Report
- March 2025
- 50 Pages
Turkey
From €533EUR$600USD£465GBP
- Report
- March 2025
- 50 Pages
Saudi Arabia
From €533EUR$600USD£465GBP
- Report
- March 2025
- 50 Pages
South Africa
From €533EUR$600USD£465GBP
- Report
- March 2025
- 50 Pages
Israel
From €533EUR$600USD£465GBP
- Report
- March 2025
- 50 Pages
Colombia
From €533EUR$600USD£465GBP
- Report
- March 2025
- 50 Pages
Argentina
From €533EUR$600USD£465GBP
- Report
- March 2025
- 50 Pages
Brazil
From €533EUR$600USD£465GBP
- Report
- March 2025
- 50 Pages
South Korea
From €533EUR$600USD£465GBP
- Report
- March 2025
- 50 Pages
India
From €533EUR$600USD£465GBP
- Report
- March 2025
- 50 Pages
Australia
From €533EUR$600USD£465GBP
- Report
- March 2025
- 50 Pages
Japan
From €533EUR$600USD£465GBP
- Report
- March 2025
- 50 Pages
China
From €533EUR$600USD£465GBP

Alpha Glucosidase Inhibitors are a class of drugs used to treat Endocrine and Metabolic Disorders. These drugs work by inhibiting the enzyme alpha-glucosidase, which is responsible for breaking down carbohydrates in the small intestine. This helps to reduce the amount of glucose absorbed into the bloodstream, which can help to control blood sugar levels. Alpha Glucosidase Inhibitors are commonly used to treat type 2 diabetes, as well as other conditions such as polycystic ovary syndrome and gestational diabetes.
Alpha Glucosidase Inhibitors are available in both oral and injectable forms. Common side effects of these drugs include abdominal pain, nausea, and diarrhea. Long-term use of these drugs can also lead to an increased risk of hypoglycemia.
Some companies that produce Alpha Glucosidase Inhibitors include Novo Nordisk, Sanofi, Eli Lilly, and Merck. Show Less Read more